DPP4 and acute pancreatitis: Although a few potential risks associated with DPP-4 inhibitors have been reported with respect to effects in the immune system and risk of acute pancreatitis, there is a relative lack of unwanted off-target or adverse effects associated with the DPP-4 inhibitors that are used therapeutically [64].